BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Shionogi sales and marketing update

Shionogi launched its 0.5 g vial of IV Finibax doripenem to treat serious and intractable infections in Japan. Prior to the launch, the National Health Insurance (NHI) set the drug price, which was approved in July, at ¥1,617...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >